Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-09-18FDA Approved: BENICAR HCT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) from Cosette Pharmaceuticals, Inc. Th…
-
FDA approval · 2012-09-18FDA Approved: TORSEMIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for torsemide from Rising Pharma Holdings, Inc., indicating regulatory approval of changes to the to…
-
FDA approval · 2012-09-18FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Original Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved the original generic product Losartan Potassium and Hydrochlorothiazide from Jubilant Cadista Pharmaceuticals Inc. for hyperten…
-
FDA approval · 2012-09-18FDA Approved: LOSARTAN POTASSIUM TABLETS, 25 MG — Original Application (Jubilant Cadista Pharmaceuticals Inc.)
The FDA approves Jubilant Cadista's Losartan Potassium tablets 25 mg as an original ANDA, providing a generic version of losartan for hypert…
-
FDA approval · 2012-09-13FDA Approved: VASERETIC — Supplemental Application (Bausch Health US, LLC)
The FDA approved a supplemental application for VASERETIC (enalapril maleate and hydrochlorothiazide) submitted by Bausch Health US, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-09-05FDA Approved: LABETALOL HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Labetalol Hydrochloride from Hospira, Inc., signaling regulatory approval of an additional or re…
-
FDA approval · 2012-09-05FDA Approved: AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approves a generic fixed-dose combination of amlodipine and benazepril hydrochloride for hypertension (ANDA 202239) by Rising Pharma Hol…
-
FDA approval · 2012-09-04FDA Approved: LABETALOL HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for labetalol hydrochloride (Hospira, Inc.), supporting the generic drug's availability.
-
FDA approval · 2012-08-24FDA Approved: LABETALOL HYDROCHLORIDE — Supplemental Application (Civica, Inc.)
The FDA approved a supplemental application for labetalol hydrochloride submitted by Civica, Inc. The snippet does not detail the specific c…
-
FDA approval · 2012-08-24FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental abbreviated new drug application for diltiazem hydrochloride from Sun Pharmaceutical, a generic calcium channel …
-
FDA approval · 2012-08-15FDA Approved: METOPROLOL SUCCINATE — Original Application (BluePoint Laboratories)
FDA approved a generic metoprolol succinate product (BluePoint Laboratories) via an Original Application (ANDA). The product is a generic be…
-
FDA approval · 2012-08-13FDA Approved: ZESTRIL — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for Zestril (lisinopril) submitted by Upsher-Smith Laboratories.
-
FDA approval · 2012-08-09FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods' original ANDA for a losartan potassium and hydrochlorothiazide combination tablet.
-
FDA approval · 2012-08-01FDA Approved: METOPROLOL SUCCINATE — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved metoprolol succinate as a generic product through an original ANDA submission by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2012-07-27FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for benazepril hydrochloride and hydrochlorothiazide (Padagis US LLC).
-
FDA approval · 2012-07-26FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
The FDA granted supplemental approval for a fixed-dose combination product of amlodipine and atorvastatin by Prasco Laboratories. This appro…
-
FDA approval · 2012-07-26FDA Approved: DIOVAN HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for DIOVAN HCT (valsartan and hydrochlorothiazide) from Novartis Pharmaceuticals Corporation.
-
FDA approval · 2012-07-20FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for losartan potassium submitted by Quallent Pharmaceuticals Health LLC under ANDA078243.
-
FDA approval · 2012-07-10FDA Approved: LABETALOL HCL — Original Application (Par Health USA, LLC)
The FDA approved the original application for Labetalol hydrochloride (LABETALOL HCL) by Par Health USA, LLC as a generic product for the tr…
-
FDA approval · 2012-06-22FDA Approved: EPLERENONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for eplerenone filed by Mylan Pharmaceuticals Inc. This action updates regulatory aspects of the…
-
FDA approval · 2012-06-11FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Triamterene and Hydrochlorothiazide from BluePoint Laboratories.
-
FDA approval · 2012-06-11FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Triamterene and Hydrochlorothiazide from BluePoint Laboratories.
-
FDA approval · 2012-05-30FDA Approved: LOSARTAN POTASSIUM — Original Application (Macleods Pharmaceuticals Limited)
FDA approves Macleods Pharmaceuticals Limited's Losartan Potassium as an original-application generic (ANDA 202230), granting marketing appr…
-
FDA approval · 2012-05-23FDA Approved: FELODIPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for felodipine submitted by Torrent Pharmaceuticals Limited, authorizing an update to an already app…
-
FDA approval · 2012-05-11FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for furosemide by Hikma Pharmaceuticals USA Inc., authorizing a generic version of the diuretic. Thi…